Search

everythinglearnresearchcommunity

for

Search:↓

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Ayurvedic treatments successfully regrew hair and reduced hair loss in a woman with alopecia areata.

JAK inhibitors help treat alopecia areata but have high recurrence after stopping.

Non-classic congenital adrenal hyperplasia (NCCAH) can mimic PCOS and requires genetic testing for proper diagnosis and treatment.

The 3D-SeboSkin model effectively simulates Hidradenitis suppurativa and is useful for future research.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

The document concludes that Borrelia afzelii causes a skin condition in France, a gene is linked to hair loss in Caucasian women, and various genetic mutations affect skin diseases.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

People with Behçet's disease can develop life-threatening lung artery aneurysms that may require surgery.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Trans-esophageal echocardiography is crucial for accurately diagnosing heart issues in lupus patients.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Anti-CD19 therapy may help treat SLE and NMOSD.

Early recognition and a team approach are crucial for managing diffuse alveolar hemorrhage in antiphospholipid syndrome.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

Prednisone has risks for lupus patients, isotretinoin is safe for mental health, transplant patients risk skin cancer, and various treatments are effective for specific skin conditions.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Olive oil compounds may help prevent cancer in animals, but human results are mixed.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

CTA is often mistaken for AA but doesn't respond to steroids and may require hair transplantation.

Interleukin-6 may play a role in causing alopecia areata.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Exprecell™ is as effective as traditional methods but produces more f-PRF and is simpler to use.

Alopecia areata patients have higher IgE and IL-13 levels, suggesting immune involvement.